Theraclion Announces 2023 Financial Results and Continues Its Roadmap - Seite 2

Results 2023

In K€

31/12/2022

31/12/2023

Var. %

Turnover

1 235

1 822

48%

Grants

7

2

-71%

Other products

125

2 093

1576%

Total Revenues

1 360

3 917

188%

COGS (purchase and stocks variation)

466

331

-29%

External charges

3 820

2 573

-33%

Personnel charges

3 102

3 153

2%

Other operational Charges

287

1 014

253%

Total operating expenses

7 675

7 070

-8%

Operating result

-6 314

-3 153

-50%

Financial result

-8

-1 955

23179%

Non recurring result

350

384

10%

R&D tax credit

-1 002

-1 049

5%

Net result

-4 971

-3 675

-26%

Accounts approved by the Board of Directors on March 26, 2023.